Thyroid Gland Disorder Treatment Market

Global Thyroid Gland Disorder Treatment Market Size, Trends & Analysis - Forecasts to 2028 By Disease Type (Hyperthyroidism, Hypothyroidism), By Drug Type (Levothyroxine, Liothyronine, Propylthiouracil, Imidazole-based Compound, Others), By Route of Administration (Oral, Intravenous, Others), and By Distribution Channel (Wholesaler/Distributor, Retailer, Mail-order Pharmacy, Others), By Region (North America, Asia Pacific, Central and South America, Europe, Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Global Thyroid Gland Disorder Treatment Market Size

The Global Thyroid Gland Disorder Treatment Market is projected to grow at a CAGR of 4.3% from 2023 to 2028.

Thyroid hormones, such as T4 (thyroxine, which includes four iodide atoms) and T3, are released and controlled by the thyroid gland (triiodothyronine, contains three iodide atoms). Thyroid gland disorder is a medical condition in which the thyroid either produces too much or too little of these hormones to aid metabolism and growth. Men, women, new-borns, teenagers, and the elderly are all likely to be diagnosed with this illness.

Thyroid disorder is caused by the deficit of iodine in the body. There is an increase in the incidence of thyroid gland disorder with around 2 billion people worldwide at risk of iodine deficiency. The developing countries have been estimated to have the highest number of undiagnosed patients as compared to major developed countries. As per statistics by the Thyroid Foundation of Canada, one in every 1700 children in Canada is affected by congenital hypothyroidism. This shows the potential demand for anti-thyroid treatment drugs in the forecast period of 2023-2028.

Furthermore, today's sedentary lifestyle and the increasing hereditary factor that contribute to a person diagnosed with thyroid are major drivers influencing the market growth.

Increased collaboration between commercial and public organisations to raise thyroid management awareness among healthcare professionals and patients is likely to drive market expansion for thyroid gland disorder treatment. There is a huge surge in the number of thyroid disease awareness programs associated with thyroid disorders. Major government organizations such as: The American Thyroid Association (ATA), American Association of Clinical Endocrinologists (AACE), British Thyroid Foundation, and Thyroid Foundation of Canada are running various promotional campaigns designed to raise awareness of thyroid problems amongst individuals and to encourage them to have it tested if they notice any symptoms.

Pharmaceutical companies are also taking advantage by inventing effective medicine combinations to treat thyroid gland disorders. They are actively participating in initiatives to assist awareness campaigns or to implement promotional strategies to educate the general public about thyroid gland disorders. This is forecasted to drive the market growth for thyroid gland disorder treatment.

global thyroid gland disorder treatment market

Global Thyroid Gland Disorder Treatment Market: By Disease Type

Based on the disease type, the market is bifurcated into hypothyroidism and hyperthyroidism. The hypothyroidism segment is expected to be the fastest-growing segment in the market from 2023-2028, owing to the increase in global prevalence for iodine deficiency. Additionally, this is the most frequent type of thyroid condition where the thyroid glands do not produce enough thyroid hormone.

Global Thyroid Gland Disorder Treatment Market: By Drug Type

The levothyroxine segment is anticipated to be the fastest-growing segment in the market from 2023-2028. The primary factor fuelling the expansion of the levothyroxine segment is the increasing usage of the drug to treat hypothyroidism. Furthermore, this segment is projected to rise as a result of increasing doctor prescription for this drug type across all geographical areas.

Global Thyroid Gland Disorder Treatment Market: By Route of Administration

Based on route of administration, the market is divided into oral, intravenous, and others. The oral segment is anticipated to be the largest contributor towards market growth because the drugs are widely available in the market in the form of oral medication such as tablets and pills. The advent of newer and more technology advanced oral agents have paved the way for the popularity of oral route of administration in the forecast period.

Global Thyroid Gland Disorder Treatment Market: By Distribution Channel

On the basis of distribution channel, thyroid gland disorder treatment market is bifurcated into wholesaler/distributor, retailer, mail-order pharmacy, and others. The wholesaler/distributor segment dominates the market due to higher penetration of these distribution channels for prescription based medicines. They offer bulk purchases at low prices, have a large inventory, and provide speedy delivery to customers, making it the most convenient option.

asia pacific thyroid gland disorder treatment market

Global Thyroid Gland Disorder Treatment Market: By Region

Geographically, the market is anticipated to retain its dominance in North America due to the presence of key players in the pharmaceutical sector, streamlined healthcare facilities, and the availability of advanced treatment options. In addition, rising awareness combined with government spending on the healthcare industry is anticipated to speed up growth. Strategic partnerships between pharmaceutical companies and government organizations are on a rise in the region catering to exhibit a lucrative market opportunity in the forecast period.

Asia Pacific is predicted to have rapid growth. The key factors that are anticipated to provide the market with lucrative growth opportunities over the forecast period is the increasing cases of thyroid disorders in developing countries, improved healthcare infrastructure and care quality, and availability of raw material and labour at lower costs. The growth of this region is also supported by rising investments of global players in local companies.

Global Thyroid Gland Disorder Treatment Market Share and Competitor Analysis

The paramount competitors covered in the global thyroid gland disorder treatment market are Abbott Laboratories, AbbVie Inc, Allergan Plc, GlaxoSmithKline plc, Lannett Company, Inc, Merck & Co. Inc, Mylan N.V, Novartis AG, Pfizer Inc, and RLC Labs, Inc. among others.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Research Methodology

1.1 Research Assumptions

1.2 Research Methodology

1.2.1 Estimates and Forecast Timeline

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GME’s Internal Database

1.3.3 Primary Research

1.3.4 Secondary Sources & Third-Party Perspectives

1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website

1.3.4.2 Secondary Data Sources

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market Route of Administration & Data Visualization

1.6 Data Validation & Publishing

1.7 Market Model

1.7.1 Model Details

1.7.1.1 Top-Down Approach

1.7.1.2 Bottom-Up Approach

1.8 Market Segmentation & Scope

1.9 Market Definition

Chapter 2 Executive Summary

2.1. Global Market Outlook

2.2 Disease Type Outlook

2.3 Drug Type Outlook

2.4 Route of Administration Outlook

2.5 Distribution Channel Outlook

2.6 Regional Outlook

Chapter 3 Global Thyroid Gland Disorder Treatment Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Metric Data

3.4 Market Dynamic

3.4.1 Market Driver Analysis

3.4.2 Market Restraint Analysis

3.4.3 Industry Challenges

3.4.4 Industry Opportunities

3.5 Porter’s Five Analysis

3.5.1 Supplier Power

3.5.2 Buyer Power

3.5.3 Substitution Threat

3.5.4 Threat from New Entrant

3.6 Market Entry Strategies

Chapter 4 Thyroid Gland Disorder Treatment Market: Disease Type Trend Analysis

4.1 Disease Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

4.2 Hypothyroidism

4.2.1 Market Estimates & Forecast Analysis of Hypothyroidism Segment, By Region, 2020-2028 (USD Billion)

4.3 Hyperthyroidism

4.3.1 Market Estimates & Forecast Analysis of Hyperthyroidism Markets Segment, By Region, 2020-2028 (USD Billion)

Chapter 5 Thyroid Gland Disorder Treatment Market: Drug Type Trend Analysis

5.1 Drug Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

5.2 Levothyroxine

5.2.1 Market Estimates & Forecast Analysis of Levothyroxine Segment, By Region, 2020-2028 (USD Billion)

5.3 Liothyronine

5.3.1 Market Estimates & Forecast Analysis of Liothyronine Segment, By Region, 2020-2028 (USD Billion)

5.4 Propylthiouracil

5.4.1 Market Estimates & Forecast Analysis of Propylthiouracil Segment, By Region, 2020-2028 (USD Billion)

5.5 Imidazole-Based Compounds

5.5.1 Market Estimates & Forecast Analysis of Imidazole-based compounds Segment, By Region, 2020-2028 (USD Billion)

5.6 Others

5.6.1 Market Estimates & Forecast Analysis Others Segment, By Region, 2020-2028 (USD Billion)

Chapter 6 Thyroid Gland Disorder Treatment Market: Route of Administration Trend Analysis

6.1 Route of Administration: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

6.2 Oral

6.2.1 Market Estimates & Forecast Analysis of Oral Segment, By Region, 2020-2028 (USD Billion)

6.3 Intravenous Route

6.3.1 Market Estimates & Forecast Analysis of Governance, Intravenous route Segment, By Region, 2020-2028 (USD Billion)

6.4 Others

6.4.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2020-2028 (USD Billion)

Chapter 7 Thyroid Gland Disorder Treatment Market: Distribution Channel Trend Analysis

7.1 Distribution Channel: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

7.2 Wholesaler/Distributor

7.2.1 Market Estimates & Forecast Analysis of Wholesaler/Distributor Segment, By Region, 2020-2028 (USD Billion)

7.3 Retailer

7.3.1 Market Estimates & Forecast Analysis of Retailer Segment, By Region, 2020-2028 (USD Billion)

7.4 Mail-Order Pharmacy

7.4.1 Market Estimates & Forecast Analysis of Mail-Order Pharmacy Segment, By Region, 2020-2028 (USD Billion)

7.5 Others

7.5.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2020-2028 (USD Billion)

Chapter 9 Thyroid Gland Disorder Treatment Market, By Region

8.1 Regional Outlook

8.2 North America

8.2.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Billion)

8.2.2 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.2.3 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.2.4 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.2.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.2.6 U.S.

8.2.6.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.2.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.2.6.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.2.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.2.7 Canada

8.2.7.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.2.7.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.2.7.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.2.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.2.8 Mexico

8.2.8.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.2.8.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.2.8.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.2.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3 Europe

8.3.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Billion)

8.3.2 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.3 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.4 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.6 Germany

8.3.6.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.6.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.7 UK

8.3.7.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.7.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.7.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.8 France

8.3.8.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.8.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.8.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.9 Russia

8.3.9.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.9.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.9.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.10 Italy

8.3.10.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.10.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.10.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.10.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.11 Spain

8.3.11.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.11.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.11.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.11.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.3.12 Rest of Europe

8.3.12.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.3.12.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.3.12.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.3.12.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4 Asia Pacific

8.4.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Billion)

8.4.2 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.3 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.4 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.6 China

8.4.6.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.6.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.7 India

8.4.7.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.7.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.7.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.8 Japan

8.4.8.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.8.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.8.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.9 Australia

8.4.9.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.9.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.9.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.10 South Korea

8.4.10.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.10.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.10.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.10.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.4.11 Rest of Asia Pacific

8.4.11.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.4.11.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.4.11.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.4.11.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.5 Central & South America

8.5.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Billion)

8.5.2 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.5.3 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.5.4 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.5.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.5.6 Brazil

8.5.6.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.5.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.5.6.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.5.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.5.7 Rest of Central & South America

8.5.7.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.5.7.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.5.7.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.5.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.6 Middle East & Africa

8.6.1 Market Estimates & Forecast Analysis, By Country 2020-2028 (USD Billion)

8.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.6.3 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.6.4 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.6.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.6.6 Saudi Arabia

8.6.6.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.6.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.6.6.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.6.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.6.7 United Arab Emirates

8.6.7.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.6.7.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.6.7.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.6.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.6.8 South Africa

8.6.8.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.6.8.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.6.8.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.6.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

8.6.9 Rest of Middle East & Africa

8.6.9.1 Market Estimates & Forecast Analysis, By Disease Type, 2020-2028 (USD Billion)

8.6.9.2 Market Estimates & Forecast Analysis, By Drug Type, 2020-2028 (USD Billion)

8.6.9.3 Market Estimates & Forecast Analysis, By Route of Administration, 2020-2028 (USD Billion)

8.6.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2020-2028 (USD Billion)

Chapter 9 Competitive Analysis

9.1 Key Global Players, Recent Developments & their Impact on the Industry

9.2 Four Quadrant Competitor Positioning Matrix

9.2.1 Key Innovators

9.2.2 Market Leaders

9.2.3 Emerging Players

9.2.4 Market Challengers

9.3 Vendor Landscape Analysis

9.4 Distribution Channel Landscape Analysis

9.5 Company Market Share Analysis, 2022

Chapter 10 Company Profile Analysis

10.1 Abbott Laboratories

10.1.1 Company Overview

10.1.2 Financial Analysis

10.1.3 Strategic Initiatives

10.1.4 Disease Type Benchmarking

10.2 AbbVie Inc

10.2.1 Company Overview

10.2.2 Financial Analysis

10.2.3 Strategic Initiatives

10.2.4 Disease Type Benchmarking

10.3 Allergan Plc

10.3.1 Company Overview

10.3.2 Financial Analysis

10.3.3 Strategic Initiatives

10.3.4 Disease Type Benchmarking

10.4 GlaxoSmithKline plc

10.4.1 Company Overview

10.4.2 Financial Analysis

10.4.3 Strategic Initiatives

10.4.4 Disease Type Benchmarking

10.5 Lannett Company, Inc

10.5.1 Company Overview

10.5.2 Financial Analysis

10.5.3 Strategic Initiatives

10.5.4 Disease Type Benchmarking

10.6 Merck & Co. Inc

10.6.1 Company Overview

10.6.2 Financial Analysis

10.6.3 Strategic Initiatives

10.6.4 Disease Type Benchmarking

10.7 Mylan N.V

10.7.1 Company Overview

10.7.2 Financial Analysis

10.7.3 Strategic Initiatives

10.7.4 Disease Type Benchmarking

10.8 Novartis AG

10.8.1 Company Overview

10.8.2 Financial Analysis

10.8.3 Strategic Initiatives

10.8.4 Disease Type Benchmarking

10.9 Pfizer Inc

10.9.1 Company Overview

10.9.2 Financial Analysis

10.9.3 Strategic Initiatives

10.9.4 Disease Type Benchmarking

10.10 RLC Labs, Inc

10.10.1 Company Overview

10.10.2 Financial Analysis

10.10.3 Strategic Initiatives

10.10.4 Disease Type Benchmarking

10.11 Other Companies

10.11.1 Company Overview

10.11.2 Financial Analysis

10.11.3 Strategic Initiatives

10.11.4 Disease Type Benchmarking

List of Tables

1 Technological Advancements In Thyroid Gland Disorder Treatment Market

2 Global Thyroid Gland Disorder Treatment Market: Key Market Drivers

3 Global Thyroid Gland Disorder Treatment Market: Key Market Challenges

4 Global Thyroid Gland Disorder Treatment Market: Key Market Opportunities

5 Global Thyroid Gland Disorder Treatment Market: Key Market Restraints

6 Global Thyroid Gland Disorder Treatment Market Estimates & Forecast Analysis, 2020-2028 (USD Billion)

7 Global Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

8 Hypothyroidism: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

9 Hyperthyroidism Markets: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

10 Global Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

11 Levothyroxine: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

12 Liothyronine: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

13 Propylthiouracil: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

14 Imidazole-based compounds: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

15 Others: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

16 Global Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

17 Oral: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

18 Intravenous route: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

19 Others: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

20 Global Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

21 Wholesaler/Distributor: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

22 Retailer: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

23 Mail-Order Pharmacy: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

24 Others: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

25 Regional Analysis: Global Thyroid Gland Disorder Treatment Market, By Region, 2020-2028 (USD Billion)

26 North America: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

27 North America: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

28 North America: Thyroid Gland Disorder Treatment Market, By Route of Administration , 2020-2028 (USD Billion)

29 North America: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

30 North America: Thyroid Gland Disorder Treatment Market, By Country, 2020-2028 (USD Billion)

31 U.S: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

32 U.S: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

33 U.S: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

34 U.S: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

35 Canada: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

36 Canada: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

37 Canada: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

38 Canada: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

39 Mexico: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

40 Mexico: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

41 Mexico: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

42 Mexico: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

43 Europe: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

44 Europe: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

45 Europe: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

46 Europe: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

47 Germany: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

48 Germany: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

49 Germany: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

50 Germany: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

51 UK: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

52 UK: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

53 UK: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

54 UK: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

55 France: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

56 France: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

57 France: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

58 France: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

59 Italy: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

60 Italy: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

61 Italy: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

62 ltaly: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

63 Spain: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

64 Spain: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

65 Spain: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

66 Spain: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

67 Rest Of Europe: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

68 Rest Of Europe: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

69 Rest Of Europe: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

70 Rest of Europe: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

71 Asia Pacific: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

72 Asia Pacific: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

73 Asia Pacific: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

74 Asia Pacific: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

75 Asia Pacific: Thyroid Gland Disorder Treatment Market, By Country, 2020-2028 (USD Billion)

76 China: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

77 China: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

78 China: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

79 China: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

80 India: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

81 India: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

82 India: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

83 India: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

84 Japan: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

85 Japan: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

86 Japan: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

87 Japan: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

88 South Korea: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

89 South Korea: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

90 South Korea: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

91 South Korea: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

92 Middle East & Africa: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

93 Middle East & Africa: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

94 Middle East & Africa: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

95 Middle East & Africa: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

96 Middle East & Africa: Thyroid Gland Disorder Treatment Market, By Country, 2020-2028 (USD Billion)

97 Saudi Arabia: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

98 Saudi Arabia: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

99 Saudi Arabia: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

100 Saudi Arabia: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

101 UAE: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

102 UAE: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

103 UAE: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

104 UAE: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

105 Central & South America: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

106 Central & South America: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

107 Central & South America: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

108 Central & South America: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

109 Central & South America: Thyroid Gland Disorder Treatment Market, By Country, 2020-2028 (USD Billion)

110 Brazil: Thyroid Gland Disorder Treatment Market, By Disease Type, 2020-2028 (USD Billion)

111 Brazil: Thyroid Gland Disorder Treatment Market, By Drug Type, 2020-2028 (USD Billion)

112 Brazil: Thyroid Gland Disorder Treatment Market, By Route of Administration, 2020-2028 (USD Billion)

113 Brazil: Thyroid Gland Disorder Treatment Market, By Distribution Channel, 2020-2028 (USD Billion)

114 Abbott Laboratories: Disease Types Offered

115 AbbVie Inc: Disease Types Offered

116 Allergan Plc: Disease Types Offered

117 GlaxoSmithKline plc: Disease Types Offered

118 Lannett Company, Inc: Disease Types Offered

119 Merck & Co. Inc: Disease Types Offered

120 Mylan N.V: Disease Types Offered

121 Novartis AG: Disease Types Offered

122 Pfizer Inc: Disease Types Offered

123 RLC Labs, Inc: Disease Types Offered

124 Other Companies: Disease Types Offered

List of Figures

1. Global Thyroid Gland Disorder Treatment Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Thyroid Gland Disorder Treatment Market: Penetration & Growth Prospect Mapping

7. Global Thyroid Gland Disorder Treatment Market: Value Chain Analysis

8. Global Thyroid Gland Disorder Treatment Market Drivers

9. Global Thyroid Gland Disorder Treatment Market Restraints

10. Global Thyroid Gland Disorder Treatment Market Opportunities

11. Global Thyroid Gland Disorder Treatment Market Challenges

12. Key Thyroid Gland Disorder Treatment Market Manufacturer Analysis

13. Global Thyroid Gland Disorder Treatment Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Abbott Laboratories: Company Snapshot

16. Abbott Laboratories: SWOT Analysis

17. AbbVie Inc: Company Snapshot

18. AbbVie Inc: SWOT Analysis

19. Allergan Plc: Company Snapshot

20. Allergan Plc: SWOT Analysis

21. GlaxoSmithKline plc: Company Snapshot

22. GlaxoSmithKline plc: SWOT Analysis

23. Lannett Company, Inc: Company Snapshot

24. Lannett Company, Inc: SWOT Analysis

25. Merck & Co. Inc: Company Snapshot

26. Merck & Co. Inc: SWOT Analysis

27. Mylan N.V: Company Snapshot

28. Mylan N.V: SWOT Analysis

29. Novartis AG: Company Snapshot

30. Novartis AG: SWOT Analysis

31. Pfizer Inc: Company Snapshot

32. Pfizer Inc: SWOT Analysis

33. RLC Labs, Inc: Company Snapshot

34. RLC Labs, Inc: SWOT Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis

The Global Thyroid Gland Disorder Treatment Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Thyroid Gland Disorder Treatment Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the thyroid gland disorder treatment market?

The global thyroid gland disorder treatment market is projected to grow at a CAGR of 4.3% from 2023 to 2028.

Who are the major vendors in the thyroid gland disorder treatment market?

The paramount competitors covered in the thyroid gland disorder treatment market report are Abbott Laboratories, AbbVie Inc, Allergan Plc, GlaxoSmithKline plc, Lannett Company, Inc, Merck & Co. Inc, Mylan N.V, Novartis AG, Pfizer Inc, and RLC Labs, Inc. among others.

What are the opportunities prevailing in the global thyroid gland disorder treatment market?

The opportunities prevailing in the global thyroid gland disorder treatment market are the rising cases of iodine deficiency incidence and increasing pool of hereditary population. Factors such as rising awareness programs of thyroid problems, invention of effective medicine combinations by pharmaceutical companies, and expansion of government programs are expected to help propel the markets growth.

What are the major drivers in the thyroid gland disorder treatment market?

The prevalence of hypothyroidism is increasing, and peoples knowledge of the condition is rising. The adoption of medications for the treatment of thyroid gland problems is predicted to increase during the forecast period as a result of various companies working with governmental organisations to raise awareness about illness management.